Emergent BioSolutions
EBS
$3.40
Share price
2.72%
Change (1 day)
-88.93%
Change (1 year)
Categories
Emergent BioSolutions (EBS) - Total assets
Total assets on the balance sheet as of June 2023 : $2.17 B
According to Emergent BioSolutions 's latest financial reports the company's total assets are $2.17 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Emergent BioSolutions - Total assets on balance sheet (from 2004 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2022-12-31 | $3.16 B | 7.02% |
| 2021-12-31 | $2.95 B | 2.63% |
| 2020-12-31 | $2.88 B | 23.78% |
| 2019-12-31 | $2.32 B | 4.48% |
| 2018-12-31 | $2.22 B | 108.32% |
| 2017-12-31 | $1.07 B | 10.32% |
| 2016-12-31 | $0.97 B | -7.04% |
| 2015-12-31 | $1.04 B | 10.4% |
| 2014-12-31 | $0.94 B | 50.85% |
| 2013-12-31 | $0.62 B | 11.06% |
| 2012-12-31 | $0.56 B | 3.18% |
| 2011-12-31 | $0.54 B | 9.3% |
| 2010-12-31 | $0.50 B | 45.15% |
| 2009-12-31 | $0.34 B | 18.54% |
| 2008-12-31 | $0.29 B | 6.32% |
| 2007-12-31 | $0.27 B | 14.8% |
| 2006-12-31 | $0.23 B | 137.47% |
| 2005-12-31 | $0.10 B | 45.29% |
| 2004-12-31 | $69.05 M | |
| 2002-12-31 | $22.79 M | -10.36% |
| 2001-12-31 | $25.42 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $195.61 B | 8,878.20% | 🇺🇸 USA |
 Merck MRK | $107.79 B | 4,847.49% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $75.00 B | 3,342.62% | 🇬🇧 UK |
 Soligenix SNGX | $11.1 M | -99.49% | 🇺🇸 USA |
 SIGA Technologies SIGA | $0.14 B | -93.28% | 🇺🇸 USA |
 Celldex Therapeutics CLDX | $0.29 B | -86.26% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $43.09 B | 1,877.92% | 🇮🇱 Israel |